oxcarbazepin orion 150 mg tabletti, kalvopäällysteinen
orion corporation - oxcarbazepine - tabletti, kalvopäällysteinen - 150 mg - okskarbatsepiini
oxcarbazepin orion 300 mg tabletti, kalvopäällysteinen
orion corporation - oxcarbazepine - tabletti, kalvopäällysteinen - 300 mg - okskarbatsepiini
oxcarbazepin orion 600 mg tabletti, kalvopäällysteinen
orion corporation - oxcarbazepine - tabletti, kalvopäällysteinen - 600 mg - okskarbatsepiini
methylphenidate mylan 18 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 18 mg - metyylifenidaatti
methylphenidate mylan 36 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 36 mg - metyylifenidaatti
methylphenidate mylan 54 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 54 mg - metyylifenidaatti
candesartan/hydrochlorothiazide orion 32 mg / 12,5 mg tabletti
orion corporation - hydrochlorothiazide, candesartan cilexetil - tabletti - 32 mg / 12,5 mg - kandesartaani ja diureetit
candesartan/hydrochlorothiazide orion 32 mg / 25 mg tabletti
orion corporation - hydrochlorothiazide, candesartan cilexetil - tabletti - 32 mg / 25 mg - kandesartaani ja diureetit
methylphenidate mylan 27 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 27 mg - metyylifenidaatti
ontozry
angelini pharma s.p.a - cenobamate - epilepsia - epilepsialääkkeet, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.